Looking forward to the presentation which undoubtedly is going to show some excellent efficacy, in addition to high safety & tolerability!
Also great news about Syntara progressing 5505 with setting up a meeting with the FDA in 1H 2025 to discuss the next steps in the clinical development program! Very promising!
- Forums
- ASX - By Stock
- SNT
- Ann: Selected for oral presentation at ASH
SNT
syntara limited
Add to My Watchlist
3.92%
!
5.3¢

Ann: Selected for oral presentation at ASH, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.3¢ |
Change
0.002(3.92%) |
Mkt cap ! $86.12M |
Open | High | Low | Value | Volume |
5.2¢ | 5.4¢ | 5.1¢ | $140.9K | 2.684M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 80163 | 5.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 47198 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10005 | 0.052 |
2 | 58560 | 0.051 |
5 | 485661 | 0.050 |
2 | 263681 | 0.049 |
4 | 281000 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 979 | 1 |
0.054 | 468340 | 1 |
0.055 | 513600 | 4 |
0.057 | 483082 | 1 |
0.058 | 201600 | 3 |
Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online